+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ReNeuron Group - logo
Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 580 Pages
  • Global
From
Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 1079 Pages
  • Global
From
Peripheral Arterial Disease (PAD)- Pipeline Insight, 2024 - Product Thumbnail Image

Peripheral Arterial Disease (PAD)- Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Huntington Disease - Pipeline Review, H1 2020 - Product Thumbnail Image

Huntington Disease - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 390 Pages
  • Global
From
ReNeuron Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

ReNeuron Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
ReNeuron Group Plc (RENE) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

ReNeuron Group Plc (RENE) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • January 2023
  • 48 Pages
From
Loading Indicator